Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)Willem Pieter Brouwer, Meral Akdoğan, Krzysztof Simon et al.|Hepatology|2014Cited by 165
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trialsGregory J. Dore, Thomas Podsadecki, Victoria Aramă et al.|Journal of Hepatology|2015Cited by 68